Global Neuromodulation Market Research Report 2023

The global Neuromodulation market was valued at US$ million in 2022 and is anticipated to reach US$ million by 2029, witnessing a CAGR of % during the forecast period 2023-2029. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.

North American market for Neuromodulation is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.

Asia-Pacific market for Neuromodulation is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.

The global market for Neuromodulation in Ischemia is estimated to increase from $ million in 2023 to $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.

The key global companies of Neuromodulation include Medtronic, Boston Scientific Corporation, Abbott, LivaNova, Synapse Biomedical, Inc., Nevro Corporation, NeuroSigma, NeuroPace and Neuronetics, etc. In 2022, the world's top three vendors accounted for approximately % of the revenue.

This report aims to provide a comprehensive presentation of the global market for Neuromodulation, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Neuromodulation.

The Neuromodulation market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Neuromodulation market comprehensively. Regional market sizes, concerning products by type, by application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Neuromodulation companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by type, by application, and by regions.

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Neuromodulation Market Size Growth Rate by Type: 2018 VS 2022 VS 2029

1.2.2 Internal Treatment

1.2.3 External Treatment

1.3 Market by Application

1.3.1 Global Neuromodulation Market Growth by Application: 2018 VS 2022 VS 2029

1.3.2 Ischemia

1.3.3 Chronic Pain

1.3.4 Parkinson’s

1.3.5 Depression

1.3.6 Tremor

1.3.7 Epilepsy

1.3.8 Migraine

1.4 Study Objectives

1.5 Years Considered

1.6 Years Considered

2.1 Global Neuromodulation Market Perspective (2018-2029)

2.2 Neuromodulation Growth Trends by Region

2.2.1 Global Neuromodulation Market Size by Region: 2018 VS 2022 VS 2029

2.2.2 Neuromodulation Historic Market Size by Region (2018-2023)

2.2.3 Neuromodulation Forecasted Market Size by Region (2024-2029)

2.3 Neuromodulation Market Dynamics

2.3.1 Neuromodulation Industry Trends

2.3.2 Neuromodulation Market Drivers

2.3.3 Neuromodulation Market Challenges

2.3.4 Neuromodulation Market Restraints

3.1 Global Top Neuromodulation Players by Revenue

3.1.1 Global Top Neuromodulation Players by Revenue (2018-2023)

3.1.2 Global Neuromodulation Revenue Market Share by Players (2018-2023)

3.2 Global Neuromodulation Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Players Covered: Ranking by Neuromodulation Revenue

3.4 Global Neuromodulation Market Concentration Ratio

3.4.1 Global Neuromodulation Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Neuromodulation Revenue in 2022

3.5 Neuromodulation Key Players Head office and Area Served

3.6 Key Players Neuromodulation Product Solution and Service

3.7 Date of Enter into Neuromodulation Market

3.8 Mergers & Acquisitions, Expansion Plans

4.1 Global Neuromodulation Historic Market Size by Type (2018-2023)

4.2 Global Neuromodulation Forecasted Market Size by Type (2024-2029)

5.1 Global Neuromodulation Historic Market Size by Application (2018-2023)

5.2 Global Neuromodulation Forecasted Market Size by Application (2024-2029)

6.1 North America Neuromodulation Market Size (2018-2029)

6.2 North America Neuromodulation Market Growth Rate by Country: 2018 VS 2022 VS 2029

6.3 North America Neuromodulation Market Size by Country (2018-2023)

6.4 North America Neuromodulation Market Size by Country (2024-2029)

6.5 United States

6.6 Canada

7.1 Europe Neuromodulation Market Size (2018-2029)

7.2 Europe Neuromodulation Market Growth Rate by Country: 2018 VS 2022 VS 2029

7.3 Europe Neuromodulation Market Size by Country (2018-2023)

7.4 Europe Neuromodulation Market Size by Country (2024-2029)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Nordic Countries

8.1 Asia-Pacific Neuromodulation Market Size (2018-2029)

8.2 Asia-Pacific Neuromodulation Market Growth Rate by Region: 2018 VS 2022 VS 2029

8.3 Asia-Pacific Neuromodulation Market Size by Region (2018-2023)

8.4 Asia-Pacific Neuromodulation Market Size by Region (2024-2029)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia

9.1 Latin America Neuromodulation Market Size (2018-2029)

9.2 Latin America Neuromodulation Market Growth Rate by Country: 2018 VS 2022 VS 2029

9.3 Latin America Neuromodulation Market Size by Country (2018-2023)

9.4 Latin America Neuromodulation Market Size by Country (2024-2029)

9.5 Mexico

9.6 Brazil

10.1 Middle East & Africa Neuromodulation Market Size (2018-2029)

10.2 Middle East & Africa Neuromodulation Market Growth Rate by Country: 2018 VS 2022 VS 2029

10.3 Middle East & Africa Neuromodulation Market Size by Country (2018-2023)

10.4 Middle East & Africa Neuromodulation Market Size by Country (2024-2029)

10.5 Turkey

10.6 Saudi Arabia

10.7 UAE

11.1 Medtronic

11.1.1 Medtronic Company Detail

11.1.2 Medtronic Business Overview

11.1.3 Medtronic Neuromodulation Introduction

11.1.4 Medtronic Revenue in Neuromodulation Business (2018-2023)

11.1.5 Medtronic Recent Development

11.2 Boston Scientific Corporation

11.2.1 Boston Scientific Corporation Company Detail

11.2.2 Boston Scientific Corporation Business Overview

11.2.3 Boston Scientific Corporation Neuromodulation Introduction

11.2.4 Boston Scientific Corporation Revenue in Neuromodulation Business (2018-2023)

11.2.5 Boston Scientific Corporation Recent Development

11.3 Abbott

11.3.1 Abbott Company Detail

11.3.2 Abbott Business Overview

11.3.3 Abbott Neuromodulation Introduction

11.3.4 Abbott Revenue in Neuromodulation Business (2018-2023)

11.3.5 Abbott Recent Development

11.4 LivaNova

11.4.1 LivaNova Company Detail

11.4.2 LivaNova Business Overview

11.4.3 LivaNova Neuromodulation Introduction

11.4.4 LivaNova Revenue in Neuromodulation Business (2018-2023)

11.4.5 LivaNova Recent Development

11.5 Synapse Biomedical, Inc.

11.5.1 Synapse Biomedical, Inc. Company Detail

11.5.2 Synapse Biomedical, Inc. Business Overview

11.5.3 Synapse Biomedical, Inc. Neuromodulation Introduction

11.5.4 Synapse Biomedical, Inc. Revenue in Neuromodulation Business (2018-2023)

11.5.5 Synapse Biomedical, Inc. Recent Development

11.6 Nevro Corporation

11.6.1 Nevro Corporation Company Detail

11.6.2 Nevro Corporation Business Overview

11.6.3 Nevro Corporation Neuromodulation Introduction

11.6.4 Nevro Corporation Revenue in Neuromodulation Business (2018-2023)

11.6.5 Nevro Corporation Recent Development

11.7 NeuroSigma

11.7.1 NeuroSigma Company Detail

11.7.2 NeuroSigma Business Overview

11.7.3 NeuroSigma Neuromodulation Introduction

11.7.4 NeuroSigma Revenue in Neuromodulation Business (2018-2023)

11.7.5 NeuroSigma Recent Development

11.8 NeuroPace

11.8.1 NeuroPace Company Detail

11.8.2 NeuroPace Business Overview

11.8.3 NeuroPace Neuromodulation Introduction

11.8.4 NeuroPace Revenue in Neuromodulation Business (2018-2023)

11.8.5 NeuroPace Recent Development

11.9 Neuronetics

11.9.1 Neuronetics Company Detail

11.9.2 Neuronetics Business Overview

11.9.3 Neuronetics Neuromodulation Introduction

11.9.4 Neuronetics Revenue in Neuromodulation Business (2018-2023)

11.9.5 Neuronetics Recent Development

11.10 BioControl Medical

11.10.1 BioControl Medical Company Detail

11.10.2 BioControl Medical Business Overview

11.10.3 BioControl Medical Neuromodulation Introduction

11.10.4 BioControl Medical Revenue in Neuromodulation Business (2018-2023)

11.10.5 BioControl Medical Recent Development

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.2 Data Source

13.2 Disclaimer

13.3 Author Details

List of Tables

    Table 1. Global Neuromodulation Market Size Growth Rate by Type (US$ Million): 2018 VS 2022 VS 2029

    Table 2. Key Players of Internal Treatment

    Table 3. Key Players of External Treatment

    Table 4. Global Neuromodulation Market Size Growth by Application (US$ Million): 2018 VS 2022 VS 2029

    Table 5. Global Neuromodulation Market Size by Region (US$ Million): 2018 VS 2022 VS 2029

    Table 6. Global Neuromodulation Market Size by Region (2018-2023) & (US$ Million)

    Table 7. Global Neuromodulation Market Share by Region (2018-2023)

    Table 8. Global Neuromodulation Forecasted Market Size by Region (2024-2029) & (US$ Million)

    Table 9. Global Neuromodulation Market Share by Region (2024-2029)

    Table 10. Neuromodulation Market Trends

    Table 11. Neuromodulation Market Drivers

    Table 12. Neuromodulation Market Challenges

    Table 13. Neuromodulation Market Restraints

    Table 14. Global Neuromodulation Revenue by Players (2018-2023) & (US$ Million)

    Table 15. Global Neuromodulation Market Share by Players (2018-2023)

    Table 16. Global Top Neuromodulation Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Neuromodulation as of 2022)

    Table 17. Ranking of Global Top Neuromodulation Companies by Revenue (US$ Million) in 2022

    Table 18. Global 5 Largest Players Market Share by Neuromodulation Revenue (CR5 and HHI) & (2018-2023)

    Table 19. Key Players Headquarters and Area Served

    Table 20. Key Players Neuromodulation Product Solution and Service

    Table 21. Date of Enter into Neuromodulation Market

    Table 22. Mergers & Acquisitions, Expansion Plans

    Table 23. Global Neuromodulation Market Size by Type (2018-2023) & (US$ Million)

    Table 24. Global Neuromodulation Revenue Market Share by Type (2018-2023)

    Table 25. Global Neuromodulation Forecasted Market Size by Type (2024-2029) & (US$ Million)

    Table 26. Global Neuromodulation Revenue Market Share by Type (2024-2029)

    Table 27. Global Neuromodulation Market Size by Application (2018-2023) & (US$ Million)

    Table 28. Global Neuromodulation Revenue Market Share by Application (2018-2023)

    Table 29. Global Neuromodulation Forecasted Market Size by Application (2024-2029) & (US$ Million)

    Table 30. Global Neuromodulation Revenue Market Share by Application (2024-2029)

    Table 31. North America Neuromodulation Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029

    Table 32. North America Neuromodulation Market Size by Country (2018-2023) & (US$ Million)

    Table 33. North America Neuromodulation Market Size by Country (2024-2029) & (US$ Million)

    Table 34. Europe Neuromodulation Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029

    Table 35. Europe Neuromodulation Market Size by Country (2018-2023) & (US$ Million)

    Table 36. Europe Neuromodulation Market Size by Country (2024-2029) & (US$ Million)

    Table 37. Asia-Pacific Neuromodulation Market Size Growth Rate by Region (US$ Million): 2018 VS 2022 VS 2029

    Table 38. Asia-Pacific Neuromodulation Market Size by Region (2018-2023) & (US$ Million)

    Table 39. Asia-Pacific Neuromodulation Market Size by Region (2024-2029) & (US$ Million)

    Table 40. Latin America Neuromodulation Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029

    Table 41. Latin America Neuromodulation Market Size by Country (2018-2023) & (US$ Million)

    Table 42. Latin America Neuromodulation Market Size by Country (2024-2029) & (US$ Million)

    Table 43. Middle East & Africa Neuromodulation Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029

    Table 44. Middle East & Africa Neuromodulation Market Size by Country (2018-2023) & (US$ Million)

    Table 45. Middle East & Africa Neuromodulation Market Size by Country (2024-2029) & (US$ Million)

    Table 46. Medtronic Company Detail

    Table 47. Medtronic Business Overview

    Table 48. Medtronic Neuromodulation Product

    Table 49. Medtronic Revenue in Neuromodulation Business (2018-2023) & (US$ Million)

    Table 50. Medtronic Recent Development

    Table 51. Boston Scientific Corporation Company Detail

    Table 52. Boston Scientific Corporation Business Overview

    Table 53. Boston Scientific Corporation Neuromodulation Product

    Table 54. Boston Scientific Corporation Revenue in Neuromodulation Business (2018-2023) & (US$ Million)

    Table 55. Boston Scientific Corporation Recent Development

    Table 56. Abbott Company Detail

    Table 57. Abbott Business Overview

    Table 58. Abbott Neuromodulation Product

    Table 59. Abbott Revenue in Neuromodulation Business (2018-2023) & (US$ Million)

    Table 60. Abbott Recent Development

    Table 61. LivaNova Company Detail

    Table 62. LivaNova Business Overview

    Table 63. LivaNova Neuromodulation Product

    Table 64. LivaNova Revenue in Neuromodulation Business (2018-2023) & (US$ Million)

    Table 65. LivaNova Recent Development

    Table 66. Synapse Biomedical, Inc. Company Detail

    Table 67. Synapse Biomedical, Inc. Business Overview

    Table 68. Synapse Biomedical, Inc. Neuromodulation Product

    Table 69. Synapse Biomedical, Inc. Revenue in Neuromodulation Business (2018-2023) & (US$ Million)

    Table 70. Synapse Biomedical, Inc. Recent Development

    Table 71. Nevro Corporation Company Detail

    Table 72. Nevro Corporation Business Overview

    Table 73. Nevro Corporation Neuromodulation Product

    Table 74. Nevro Corporation Revenue in Neuromodulation Business (2018-2023) & (US$ Million)

    Table 75. Nevro Corporation Recent Development

    Table 76. NeuroSigma Company Detail

    Table 77. NeuroSigma Business Overview

    Table 78. NeuroSigma Neuromodulation Product

    Table 79. NeuroSigma Revenue in Neuromodulation Business (2018-2023) & (US$ Million)

    Table 80. NeuroSigma Recent Development

    Table 81. NeuroPace Company Detail

    Table 82. NeuroPace Business Overview

    Table 83. NeuroPace Neuromodulation Product

    Table 84. NeuroPace Revenue in Neuromodulation Business (2018-2023) & (US$ Million)

    Table 85. NeuroPace Recent Development

    Table 86. Neuronetics Company Detail

    Table 87. Neuronetics Business Overview

    Table 88. Neuronetics Neuromodulation Product

    Table 89. Neuronetics Revenue in Neuromodulation Business (2018-2023) & (US$ Million)

    Table 90. Neuronetics Recent Development

    Table 91. BioControl Medical Company Detail

    Table 92. BioControl Medical Business Overview

    Table 93. BioControl Medical Neuromodulation Product

    Table 94. BioControl Medical Revenue in Neuromodulation Business (2018-2023) & (US$ Million)

    Table 95. BioControl Medical Recent Development

    Table 96. Research Programs/Design for This Report

    Table 97. Key Data Information from Secondary Sources

    Table 98. Key Data Information from Primary Sources

List of Figures

    Figure 1. Global Neuromodulation Market Size Comparison by Type (2023-2029) & (US$ Million)

    Figure 2. Global Neuromodulation Market Share by Type: 2022 VS 2029

    Figure 3. Internal Treatment Features

    Figure 4. External Treatment Features

    Figure 5. Global Neuromodulation Market Size Comparison by Application (2023-2029) & (US$ Million)

    Figure 6. Global Neuromodulation Market Share by Application: 2022 VS 2029

    Figure 7. Ischemia Case Studies

    Figure 8. Chronic Pain Case Studies

    Figure 9. Parkinson’s Case Studies

    Figure 10. Depression Case Studies

    Figure 11. Tremor Case Studies

    Figure 12. Epilepsy Case Studies

    Figure 13. Migraine Case Studies

    Figure 14. Neuromodulation Report Years Considered

    Figure 15. Global Neuromodulation Market Size (US$ Million), Year-over-Year: 2018-2029

    Figure 16. Global Neuromodulation Market Size, (US$ Million), 2018 VS 2022 VS 2029

    Figure 17. Global Neuromodulation Market Share by Region: 2022 VS 2029

    Figure 18. Global Neuromodulation Market Share by Players in 2022

    Figure 19. Global Top Neuromodulation Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Neuromodulation as of 2022)

    Figure 20. The Top 10 and 5 Players Market Share by Neuromodulation Revenue in 2022

    Figure 21. North America Neuromodulation Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 22. North America Neuromodulation Market Share by Country (2018-2029)

    Figure 23. United States Neuromodulation Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 24. Canada Neuromodulation Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 25. Europe Neuromodulation Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 26. Europe Neuromodulation Market Share by Country (2018-2029)

    Figure 27. Germany Neuromodulation Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 28. France Neuromodulation Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 29. U.K. Neuromodulation Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 30. Italy Neuromodulation Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 31. Russia Neuromodulation Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 32. Nordic Countries Neuromodulation Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 33. Asia-Pacific Neuromodulation Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 34. Asia-Pacific Neuromodulation Market Share by Region (2018-2029)

    Figure 35. China Neuromodulation Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 36. Japan Neuromodulation Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 37. South Korea Neuromodulation Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 38. Southeast Asia Neuromodulation Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 39. India Neuromodulation Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 40. Australia Neuromodulation Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 41. Latin America Neuromodulation Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 42. Latin America Neuromodulation Market Share by Country (2018-2029)

    Figure 43. Mexico Neuromodulation Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 44. Brazil Neuromodulation Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 45. Middle East & Africa Neuromodulation Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 46. Middle East & Africa Neuromodulation Market Share by Country (2018-2029)

    Figure 47. Turkey Neuromodulation Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 48. Saudi Arabia Neuromodulation Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 49. Medtronic Revenue Growth Rate in Neuromodulation Business (2018-2023)

    Figure 50. Boston Scientific Corporation Revenue Growth Rate in Neuromodulation Business (2018-2023)

    Figure 51. Abbott Revenue Growth Rate in Neuromodulation Business (2018-2023)

    Figure 52. LivaNova Revenue Growth Rate in Neuromodulation Business (2018-2023)

    Figure 53. Synapse Biomedical, Inc. Revenue Growth Rate in Neuromodulation Business (2018-2023)

    Figure 54. Nevro Corporation Revenue Growth Rate in Neuromodulation Business (2018-2023)

    Figure 55. NeuroSigma Revenue Growth Rate in Neuromodulation Business (2018-2023)

    Figure 56. NeuroPace Revenue Growth Rate in Neuromodulation Business (2018-2023)

    Figure 57. Neuronetics Revenue Growth Rate in Neuromodulation Business (2018-2023)

    Figure 58. BioControl Medical Revenue Growth Rate in Neuromodulation Business (2018-2023)

    Figure 59. Bottom-up and Top-down Approaches for This Report

    Figure 60. Data Triangulation

    Figure 61. Key Executives Interviewed